Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury

NCT02657135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2018-07-23

No results posted yet for this study

Summary

TEAM-TBI (Targeted Evaluation, Action, and Monitoring of Traumatic Brain Injury) is a research study that brings together TBI patients, advanced evaluation methods, and experts in a multi-faceted study to address the heterogeneity of TBI and to evaluate the effects self-help strategies might have on TBI outcomes.

Conditions

  • Traumatic Brain Injury (TBI)

Interventions

BEHAVIORAL

Cognitive/Neuropsychological Testing

These tests will be used to determine how the participant will continue with future procedures, and depending on results, may involve the participant returning to complete subsequent testing.

OTHER

Vestibular/Ocular-Motor Testing

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI and will include dizziness, balance, ocular-motor coordination, and reflexes.

OTHER

Cervical (Neck) Evaluation

These assessments will involve a series of tests and questionnaires that focus on physical symptoms of TBI including neck mobility and pain levels.

OTHER

Sleep Evaluation

These evaluations will focus on assessing insomnia (duration, frequency, daytime consequences), combat exposure, and the presence and severity of trauma history.

OTHER

HDFT MRI

This MRI aims at providing qualitative and quantitative assessments of the nature, location, and extent of white matter injury.

OTHER

MR Spectroscopy (MRS)

This is a noninvasive diagnostic test for measuring biochemical changes in the brain.

OTHER

MEG (Magnetoencephalography)

This is a non-invasive neurophysiological technique that measures the magnetic fields generated by neuronal activity of the brain.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • University of Pittsburgh

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-24
Primary Completion
2018-03-23
Completion
2018-03-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657135 on ClinicalTrials.gov